Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
1.980
-0.110 (-5.26%)
At close: Oct 9, 2025, 4:00 PM EDT
2.047
+0.067 (3.40%)
Pre-market: Oct 10, 2025, 8:15 AM EDT
Hyperfine Revenue
Hyperfine had revenue of $2.70M in the quarter ending June 30, 2025, a decrease of -25.75%. This brings the company's revenue in the last twelve months to $10.80M, down -9.59% year-over-year. In the year 2024, Hyperfine had annual revenue of $12.89M with 16.84% growth.
Revenue (ttm)
$10.80M
Revenue Growth
-9.59%
P/S Ratio
13.73
Revenue / Employee
$97,270
Employees
111
Market Cap
155.59M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12.89M | 1.86M | 16.84% |
| Dec 31, 2023 | 11.03M | 4.22M | 61.90% |
| Dec 31, 2022 | 6.81M | 5.32M | 355.48% |
| Dec 31, 2021 | 1.50M | 1.20M | 408.84% |
| Dec 31, 2020 | 294.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
HYPR News
- 4 days ago - Hyperfine Launches PULSE Platform to Accelerate Adoption and Innovation of AI-Powered Portable MRI - Business Wire
- 5 weeks ago - Hyperfine Receives CE Mark and UKCA Approval for Optive AI™ Software, Expanding Global Commercialization of Latest AI-Powered Imaging Software - Business Wire
- 6 weeks ago - Hyperfine, Inc. to Participate in Upcoming Investor Conferences - Business Wire
- 2 months ago - Hyperfine, Inc. (HYPR) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Hyperfine, Inc. Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System - Business Wire
- 2 months ago - Hyperfine Announces First Patients Enrolled in PRIME Study Aimed at Accelerating Adoption of AI-Powered Portable MRI in Emergency Departments - Business Wire
- 2 months ago - Hyperfine, Inc. to Announce Second Quarter 2025 Financial Results on August 13, 2025 - Business Wire